Related Experiment Videos
CD30 expression in seminoma
A Hittmair1, H Rogatsch, A Hobisch
1Department of Pathology, University of Innsbruck, Austria.
Human Pathology
|November 1, 1996
Summary
CD30 antigen is not exclusive to embryonal carcinoma; it is also found in seminoma, suggesting a close relationship and potential transformation. This finding impacts understanding of testicular germ cell tumor development.
Area of Science:
- Oncology
- Pathology
- Immunohistochemistry
Background:
- CD30 antigen is a known marker for embryonal carcinoma in testicular germ cell tumors.
- Monoclonal antibody Ber-H2 effectively detects CD30 in paraffin-embedded tissue.
- Embryonal carcinoma is believed to be histogenetically related to, and possibly derived from, seminoma.
Observation:
- An immunohistochemical study investigated CD30 expression in various seminoma types.
- 38 cases of testicular seminomas were analyzed using Ber-H2, cytokeratins, and placental alkaline phosphatase.
- Consecutive sections were used to assess CD30 and cytokeratin colocalization.
Findings:
- CD30 was detected focally in 4/21 pure classic seminomas and 7/14 mixed tumors.
- Spermatocytic seminoma and intratubular germ cell neoplasia were negative for CD30.
- CD30 expression in seminoma cells occurred with or without cytokeratin coexpression.
Implications:
- CD30 expression in testicular germ cell tumors is not limited to embryonal carcinoma.
- Focal CD30 positivity in seminoma supports a close histogenetic link between seminoma and embryonal carcinoma.
- Coexpression of CD30 and cytokeratins in seminomas may indicate early transformation towards embryonal carcinoma, positioning seminoma centrally in germ cell tumor development.